The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling
Open accessAbstract
The impact of progestins on estrogen-inducible mechanisms of neuroprotection was investigated. Previously, we showed that estrogen and progesterone are neuroprotective against excitotoxicity, whereas the synthetic progestin medroxyprogesterone acetate (MPA; Provera) is not. Here, we demonstrate that 17β-estradiol (E 2) and progesterone (P 4) treatment of hippocampal neurons attenuated the excitotoxic glutamate-induced rise in intracellular calcium concentration. Although MPA had no effect alone, MPA completely antagonized E 2-induced attenuation of intracellular calcium concentration. Activation of extracellular receptor kinase (ERK) is required for estrogen-induced neuroprotection and calcium regulation. Paradoxically, E 2, P 4, and MPA all elicited similar rapid and transient activation of ERK, presenting a contradiction between the dependence on ERK for gonadal hormone-induced neuroprotection and the lack of neuroprotection induced by MPA. Subcellular analysis of ERK demonstrated that the phospho-ERK signal is transduced to the nucleus only by E 2 and P 4, not by MPA. These results indicate that the profile of nuclear translocation of ERK is consistent with the neuroprotective profile. Further, the E 2-induced nuclear translocation of ERK was blocked by coadministration of MPA. Results of this study reveal that nuclear ERK induction by ovarian steroids is predictive of the neuroprotective effects of estrogen and progestin treatments, revealing a hitherto unrecognized divergence of progestin signaling through the src/MAPK pathway. These results have much broader implications encompassing the impact of progestins on estrogen-mediated effects in multiple tissues. The recent results from the Women's Health Initiative trial, which used MPA as the progestinal agent, indicate that differences between progestin formulations are crucial to health outcomes in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Cowley, S. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,966
Ionic dependence of glutamate neurotoxicity
Choi, D. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,802
Nuclear localization and regulation of erk- and rsk-encoded protein kinases.
Chen, R. H., Sarnecki, C., & Blenis, J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.915 · Cited by 1,091
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
Zandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Traverse, S., Gomez, N., Paterson, H., Marshall, C., & Cohen, P. (1992) · Biochemical Journal · doi:10.1042/bj2880351 · Cited by 874
Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., & Dorsa, D. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02455.1999 · Cited by 577
Oral Contraceptives and the Risk of Breast Cancer
Marchbanks, P. A., McDonald, J. A., Wilson, H. G., Folger, S. G., Mandel, M. G., Daling, J. R., Bernstein, L., Malone, K. E., Ursin, G., Strom, B. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013202 · Cited by 532
Neuroprotective effects of estrogens: potential mechanisms of action
Green, P. S., & Simpkins, J. W. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00017-4 · Cited by 523
Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro.
Robbins, D. J., Zhen, E., Owaki, H., Vanderbilt, C. A., Ebert, D., Geppert, T. D., & Cobb, M. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53507-9 · Cited by 497
Singh, M., Sétáló, G., Guan, X., Warren, M., & Toran-Allerand, C. D. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01179.1999 · Cited by 470
Oral contraceptives and the risk of breast cancer*
(2003) · Obstetrics & Gynecology · doi:10.1097/00006250-200304000-00031 · Cited by 431
Fukuda, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1901 · Cited by 383
Furuchi, T., & Anderson, R. G. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21099 · Cited by 371
Nilsen, J., & Brinton, R. D. (2002) · Endocrinology · doi:10.1210/en.143.1.205 · Cited by 342
Self-citationThe risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
FALKEBORN, M., PERSSON, I., ADAMI, H., BERGSTRÖM, R., EAKER, E., LITHELL, H., MOHSEN, R., & NAESSEN, T. (1992) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb14414.x · Cited by 333
Adachi, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5347 · Cited by 268
Nilsen, J., & Brinton, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438041100 · Cited by 262
Self-citationMedroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
Miyagawa, K., Rösch, J., Stanczyk, F., & Hermsmeyer, K. (1997) · Nature Medicine · doi:10.1038/nm0397-324 · Cited by 248
The Molecular and Neuroanatomical Basis for Estrogen Effects in the Central Nervous System
McEwen, B. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1790 · Cited by 226
Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., Böttner, M., & Rosewell, K. L. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00136-9 · Cited by 208
Lenormand, P., Brondello, J.-M., Brunet, A., & Pouysségur, J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.625 · Cited by 207
Jaaro, H., Rubinfeld, H., Hanoch, T., & Seger, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3742 · Cited by 180
Brinton, R. D. (2001) · Learning & Memory · doi:10.1101/lm.39601 · Cited by 175
Self-citationEstrogen and Stroke: A Balanced Analysis
Hurn, P. D., & Brass, L. M. (2003) · Stroke · doi:10.1161/01.str.0000054051.88378.25 · Cited by 158
Wade, C. B., & Dorsa, D. M. (2003) · Endocrinology · doi:10.1210/en.2002-220899 · Cited by 156
Nilsen, J., Chen, S., & Brinton, R. D. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02254-0 · Cited by 137
Self-citationPrevention of endometrial cancer with progestogens
Gambrell, R. D. (1986) · Maturitas · doi:10.1016/0378-5122(86)90022-8 · Cited by 123
Impact of progestins on estradiol potentiation of the glutamate calcium response
Nilsen, J., & Brinton, R. D. (2002) · Neuroreport · doi:10.1097/00001756-200205070-00018 · Cited by 111
Self-citationReszka, A. A., Bulinski, J. C., Krebs, E. G., & Fischer, E. H. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.7.1219 · Cited by 96
Cellular components of nerve growth factor signaling
Szeberényi, J., & Erhardt, P. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90168-6 · Cited by 56
Sétáló, G., Singh, M., Guan, X., & Toran‐Allerand, C. D. (2001) · Journal of Neurobiology · doi:10.1002/neu.10000 · Cited by 56
Henderson, V. W. (2000) · Novartis Foundation symposium · doi:10.1002/0470870818.ch18 · Cited by 48
Hirvonen, E. (1996) · Maturitas · doi:10.1016/0378-5122(96)01005-5 · Cited by 21
Gene activation pathways of nerve growth factor signaling: a minireview.
Szeberényi, J. (1996) · PubMed · Cited by 19
Cited by
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Self-citationSex differences in cognitive impairment and Alzheimer’s disease
Li, R., & Singh, M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.002 · Cited by 527
Protective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse
Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00036.2014 · Cited by 470
The influence of sex and gender on the immune response
Oertelt-Prigione, S. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.022 · Cited by 459
Metadata
- Authors
- Nilsen, J., & Brinton, R. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-08-18
- Volume
- 100
- Issue
- 18
- Pages
- 10506-10511
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2069327573
- Cited by
- 252
- References
- 39
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.